1. Chemical restraint may only be used on a person with a disability who is a consumer if:
(a) The consumer has been deemed to be a person in a mental health crisis, as defined in NRS 433A.0175, and is receiving mental health services from a facility;
(b) The chemical restraint is administered to the consumer while he or she is under the care of the facility;
(c) An emergency exists that necessitates the use of chemical restraint;
(d) A medical order authorizing the use of chemical restraint is obtained from the consumer’s attending physician, psychiatrist or advanced practice registered nurse;
(e) The physician, psychiatrist or advanced practice registered nurse who signed the order required pursuant to paragraph (d) examines the consumer not later than 1 working day immediately after the administration of the chemical restraint; and
(f) The chemical restraint is administered by a person licensed to administer medication.
2. If chemical restraint is used on a person with a disability who is a consumer, the use of the procedure must be reported as a denial of rights pursuant to NRS 433.534 or 435.610, as applicable, regardless of whether the use of the procedure is authorized by statute. The report must be made not later than 1 working day after the procedure is used.
(Added to NRS by 1999, 3232; A 2011, 422; 2013, 3013; 2017, 1747; 2019, 347)